Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.43 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | ADH4 | P08319 | 1/20 | 0.42 |
| ▸ | ADH7 | P40394 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octadecylamine SCHEMBL323069 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL28544584 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL28538944 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL28544340 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL1489420 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL1489065 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL11684976 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Decylamine SCHEMBL29208196 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Dodecylamine SCHEMBL5968270 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A | |
| Formic Acid SCHEMBL28112450 | 1.00 | DNM1 (0.68) | DNM1TSHREPHX1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115025883-A | Efficient flotation reagent suitable for potassium chloride direct flotation production | 华东理工大学 | 2022-09-09 | — | — | CN | claimed |
| CN-115025883-A | Efficient flotation reagent suitable for potassium chloride direct flotation production | 华东理工大学 | 2022-09-09 | — | — | CN | disclosed |
| US-20120196989-A1 | SYNTHESIS OF HOMOPOLYMERS AND BLOCK COPOLYMERS | INTEZYNE TECHNOLOGIES, INCORPORATED (US) | 2012-08-02 | — | — | US | disclosed |
| US-20110124840-A1 | Synthesis of Homopolymers and Block Copolymers | INTEZYNE TECHNOLOGIES, INC. | 2011-05-26 | — | — | US | disclosed |
| EP-1848460-A2 | SYNTHESIS OF HOMOPOLYMERS AND BLOCK COPOLYMERS | Intezyne Technologies Incorporated (US) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006086325-A2 | SYNTHESIS OF HOMOPOLYMERS AND BLOCK COPOLYMERS | INTEZYNE TECHNOLOGIES, INCORPORATED (US) | 2006-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124840-A1 | Synthesis of Homopolymers and Block Copolymers | PARG, PCNA, PARN | DNM1 1186/4885TSHR 4590/4885EPHX1 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.